Aclarion, Inc. SEC filings ACON

Aclarion, Inc. has 276 filings in SEC EDGAR's recent list, going back to Mar 3, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jun 4, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Aclarion, Inc. SEC filings
Form Description Filed Period
10-K Annual report Mar 18, 2026 Dec 31, 2025
10-K Annual report Apr 9, 2025 Dec 31, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K/A Amended annual report Jun 12, 2023 Dec 31, 2022
10-K Annual report Feb 27, 2023 Dec 31, 2022

Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
ACON (Nasdaq), ACONW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Broomfield, CO
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1635077
Former names
Nocimed, Inc. (until Oct 26, 2021)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.